These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 16145678)

  • 1. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
    Garnero P; Peterfy C; Zaim S; Schoenharting M
    Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
    Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
    Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown.
    Ding C; Garnero P; Cicuttini F; Scott F; Cooley H; Jones G
    Osteoarthritis Cartilage; 2005 Mar; 13(3):198-205. PubMed ID: 15727885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
    Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
    Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
    Garnero P; Aronstein WS; Cohen SB; Conaghan PG; Cline GA; Christiansen C; Beary JF; Meyer JM; Bingham CO
    Osteoarthritis Cartilage; 2008 Jun; 16(6):660-6. PubMed ID: 17993283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease.
    Wang B; Pramono HK; Cicuttini FM; Hanna F; Davis SR; Bell RJ; Wang Y
    Osteoarthritis Cartilage; 2014 Aug; 22(8):1136-41. PubMed ID: 24971869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
    Rousseau JC; Chevrel G; Schott AM; Garnero P
    Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
    Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
    Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
    Dam EB; Byrjalsen I; Karsdal MA; Qvist P; Christiansen C
    Osteoarthritis Cartilage; 2009 Mar; 17(3):384-9. PubMed ID: 18768336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.
    Christgau S; Henrotin Y; Tankó LB; Rovati LC; Collette J; Bruyere O; Deroisy R; Reginster JY
    Clin Exp Rheumatol; 2004; 22(1):36-42. PubMed ID: 15005002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.
    Bihlet AR; Byrjalsen I; Bay-Jensen AC; Andersen JR; Christiansen C; Riis BJ; Karsdal MA
    Arthritis Res Ther; 2019 Sep; 21(1):203. PubMed ID: 31481084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Arlot M; Christiansen C; Delmas PD
    Arthritis Rheum; 2004 Oct; 50(10):3137-44. PubMed ID: 15476251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis.
    Huebner JL; Bay-Jensen AC; Huffman KM; He Y; Leeming DJ; McDaniel GE; Karsdal MA; Kraus VB
    Arthritis Rheumatol; 2014 Sep; 66(9):2440-9. PubMed ID: 24909851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new marker for osteoarthritis: cross-sectional and longitudinal approach.
    Reijman M; Hazes JM; Bierma-Zeinstra SM; Koes BW; Christgau S; Christiansen C; Uitterlinden AG; Pols HA
    Arthritis Rheum; 2004 Aug; 50(8):2471-8. PubMed ID: 15334460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
    Karsdal MA; Byrjalsen I; Bay-Jensen AC; Henriksen K; Riis BJ; Christiansen C
    BMC Musculoskelet Disord; 2010 Jun; 11():125. PubMed ID: 20565725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.
    Roemer FW; Aydemir A; Lohmander S; Crema MD; Marra MD; Muurahainen N; Felson DT; Eckstein F; Guermazi A
    BMC Musculoskelet Disord; 2016 Jul; 17():267. PubMed ID: 27393009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The degeneration and destruction of femoral articular cartilage shows a greater degree of deterioration than that of the tibial and patellar articular cartilage in early stage knee osteoarthritis: a cross-sectional study.
    Hada S; Kaneko H; Sadatsuki R; Liu L; Futami I; Kinoshita M; Yusup A; Saita Y; Takazawa Y; Ikeda H; Kaneko K; Ishijima M
    Osteoarthritis Cartilage; 2014 Oct; 22(10):1583-9. PubMed ID: 25278068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
    Klocke R; Levasseur K; Kitas GD; Smith JP; Hirsch G
    Rheumatol Int; 2018 Mar; 38(3):455-459. PubMed ID: 29396701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.